ARTICLE | Clinical News
AVI BioPharma starts Phase III Avicine trial
January 4, 2001 8:00 AM UTC
AVII began an 800-patient Phase III trial of Avicine synthetic peptide vaccine against human chorionic gonadotropin (hCG) to treat colorectal cancer. The study will compare Avicine plus chemotherapy t...